About Dr. Zhang Xiangyan
Dr. Zhang Xiangyan (张湘燕) is Chief Physician, Professor, and Director of the Interventional Pulmonology Department at Shanghai Pulmonary Hospital, Tongji University School of Medicine — China's largest and most specialized pulmonary disease center and one of Asia's leading institutions for advanced bronchoscopic intervention. She is one of China's foremost interventional pulmonologists, with expertise spanning the full spectrum of diagnostic and therapeutic bronchoscopic procedures, from endobronchial ultrasound (EBUS) and navigational bronchoscopy for lung nodule diagnosis to airway stenting, bronchoscopic tumor ablation, and bronchoscopic lung volume reduction for emphysema.
Dr. Zhang's clinical program is defined by its breadth and technical depth. Her department performs thousands of bronchoscopic procedures annually, including complex cases referred from across China and internationally that require the most advanced bronchoscopic techniques. For patients with central airway obstruction — whether from primary lung cancer, metastatic disease, or benign strictures — her expertise in rigid bronchoscopy, laser ablation, argon plasma coagulation (APC), cryotherapy, and airway stenting provides a comprehensive toolkit for restoring airway patency and relieving symptoms. For patients with peripheral pulmonary nodules requiring tissue diagnosis, her program offers navigational bronchoscopy (including electromagnetic navigation and radial EBUS with fluoroscopy) as a minimally invasive alternative to CT-guided biopsy or surgical resection.
Dr. Zhang is also a recognized leader in bronchoscopic lung volume reduction (BLVR) for severe emphysema, including endobronchial valve (EBV) placement — a procedure that can significantly improve lung function and quality of life in carefully selected patients with heterogeneous emphysema and intact interlobar fissures. This procedure remains unavailable or inaccessible in many countries, and Shanghai Pulmonary Hospital is one of China's most experienced centers for BLVR.
Hospital Affiliation: Shanghai Pulmonary Hospital
Shanghai Pulmonary Hospital (同济大学附属上海市肺科医院) is China's largest and most specialized pulmonary disease center, affiliated with Tongji University School of Medicine. The Interventional Pulmonology Department is one of the largest and most technically advanced in Asia, equipped with the full range of flexible and rigid bronchoscopic platforms, electromagnetic navigation systems, radial and linear EBUS, cryobiopsy systems, laser and APC ablation units, and a comprehensive airway stent inventory. The department operates a dedicated bronchoscopy suite with fluoroscopic guidance and a multidisciplinary team that integrates interventional pulmonology, thoracic surgery, radiology, and oncology for complex case planning.
Clinical Expertise
- Endobronchial ultrasound (EBUS) — linear EBUS-TBNA for mediastinal and hilar lymph node sampling; radial EBUS for peripheral pulmonary lesion localization; EBUS-guided diagnosis of sarcoidosis, lymphoma, and lung cancer staging
- Navigational bronchoscopy — electromagnetic navigation bronchoscopy (ENB) for peripheral pulmonary nodules; radial EBUS with fluoroscopy; cone-beam CT-guided bronchoscopy; minimally invasive tissue diagnosis for small peripheral nodules
- Transbronchial lung cryobiopsy (TBLC) — minimally invasive lung biopsy for interstitial lung disease diagnosis; high diagnostic yield with lower risk than surgical lung biopsy
- Central airway obstruction management — rigid bronchoscopy; Nd:YAG laser ablation; argon plasma coagulation (APC); cryotherapy; electrocautery; photodynamic therapy (PDT); mechanical debulking; balloon dilation
- Airway stenting — self-expanding metallic stents (SEMS); silicone stents; Y-stents for carina involvement; biodegradable stents; stent management and replacement
- Bronchoscopic lung volume reduction (BLVR) — endobronchial valve (EBV) placement for heterogeneous emphysema; patient selection and fissure integrity assessment; post-procedure monitoring and valve management
- Bronchopleural fistula management — bronchoscopic occlusion techniques; endobronchial valve placement for persistent air leak; coordination with thoracic surgery
- Bronchoscopic treatment of hemoptysis — bronchoscopic localization and control of bleeding; endobronchial tamponade; coordination with interventional radiology for bronchial artery embolization
- Pleural procedures — medical thoracoscopy (pleuroscopy) for pleural effusion diagnosis and management; talc pleurodesis; indwelling pleural catheter placement
- Airway foreign body removal — flexible and rigid bronchoscopic foreign body extraction in adults and children
Academic Leadership & Research Contributions
Dr. Zhang Xiangyan has contributed extensively to the development of interventional pulmonology in China, with publications in leading respiratory medicine and bronchoscopy journals covering EBUS-TBNA diagnostic accuracy, navigational bronchoscopy outcomes, TBLC for ILD diagnosis, and bronchoscopic lung volume reduction results. Her research has informed national guidelines for interventional pulmonology procedures and contributed to the evidence base for advanced bronchoscopic techniques in China.
She is an active member of the Chinese Thoracic Society interventional pulmonology working group and has contributed to the development of training standards and clinical protocols for bronchoscopic procedures in China. Dr. Zhang has presented her research at major international respiratory medicine congresses including ERS, ATS, and the World Association for Bronchology and Interventional Pulmonology (WABIP), and is recognized internationally as a key opinion leader in interventional pulmonology.
Her training program at Shanghai Pulmonary Hospital has produced interventional pulmonologists who now lead programs at major hospitals across China, and she has conducted live bronchoscopy demonstration programs for pulmonologists from across Asia.
Why International Patients Choose Dr. Zhang Xiangyan
For international patients requiring advanced bronchoscopic diagnosis or treatment — whether for lung nodule biopsy, airway obstruction, emphysema, or complex pleural disease — Dr. Zhang's program at Shanghai Pulmonary Hospital offers a combination of technical expertise, procedural volume, and equipment availability that is genuinely among the best in Asia.
For patients with peripheral pulmonary nodules who wish to avoid CT-guided biopsy or surgical resection, navigational bronchoscopy at Shanghai Pulmonary Hospital provides a minimally invasive diagnostic option with high yield and low complication rates. For patients with central airway obstruction from malignancy — a condition that can cause severe breathlessness and is a medical emergency in its most acute form — Dr. Zhang's comprehensive toolkit for airway recanalization can provide rapid, durable relief that significantly improves quality of life and may enable continuation of systemic cancer treatment.
For patients with severe emphysema who are candidates for bronchoscopic lung volume reduction, Shanghai Pulmonary Hospital's BLVR program offers access to endobronchial valve placement with a team that has performed this procedure in a large number of patients — experience that directly translates to better patient selection, procedural safety, and outcomes.
Treatment costs at Shanghai Pulmonary Hospital are substantially lower than equivalent interventional pulmonology procedures in Western healthcare systems, and the speed of access to specialist consultation and procedure scheduling is typically far faster than in public healthcare systems abroad.
What to Expect at Your Consultation
Consultations with Dr. Zhang begin with a comprehensive review of all prior imaging (CT chest with thin-slice reconstruction is essential for nodule and airway assessment), pulmonary function tests, bronchoscopy reports if prior procedures have been performed, and relevant oncology or pathology records. CMCS will arrange certified translation of all medical records and imaging in advance.
Dr. Zhang will assess the most appropriate diagnostic or therapeutic bronchoscopic approach for the patient's specific situation, outline the procedure, expected outcomes, risks, and recovery, and provide a clear plan for follow-up. For patients requiring urgent airway intervention, CMCS can facilitate expedited scheduling. A written English-language consultation summary is provided after every appointment.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking interventional pulmonology consultation and procedures with Dr. Zhang Xiangyan at Shanghai Pulmonary Hospital. Our services include priority consultation and procedure scheduling, certified medical record and imaging translation, pre-consultation CT and pathology review, procedure logistics, on-site interpretation, and post-procedure follow-up coordination.
📧 contract@medicalsh.com | 💬 WeChat: gezhanglao | 🌐 medicalsh.com
0件のコメント